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Liddle's syndromeStudies aiming at the elucidation of the genetic basis of rare monogenic forms of hypertension have
identiﬁed mutations in genes coding for the epithelial sodium channel ENaC, for the mineralocorticoid
receptor, or for enzymes crucial for the synthesis of aldosterone. These genetic studies clearly demonstrate
the importance of the regulation of Na+ absorption in the aldosterone-sensitive distal nephron (ASDN), for
the maintenance of the extracellular ﬂuid volume and blood pressure.
Recent studies aiming at a better understanding of the cellular and molecular basis of ENaC-mediated Na+
absorption in the distal part of nephron, have essentially focused on the regulation ENaC activity and on the
aldosterone-signaling cascade. ENaC is a constitutively open channel, and factors controlling the number of
active channels at the cell surface are likely to have profound effects on Na+ absorption in the ASDN, and in
the amount of Na+ that is excreted in the ﬁnal urine.
A number of membrane-bound proteases, kinases, have recently been identiﬁed that increase ENaC activity
at the cell surface in heterologous expressions systems. Ubiquitylation is a general process that regulates the
stability of a variety of target proteins that include ENaC. Recently, deubiquitylating enzymes have been
shown to increase ENaC activity in heterologous expressions systems.
These regulatory mechanisms are likely to be nephron speciﬁc, since in vivo studies indicate that the
adaptation of the renal excretion of Na+ in response to Na+ diet occurs predominantly in the early part (the
connecting tubule) of the ASDN.
An important work is presently done to determine in vivo the physiological relevance of these cellular and
molecular mechanisms in regulation of ENaC activity. The contribution of the protease-dependent ENaC
regulation in mediating Na+ absorption in the ASDN is still not clearly understood. The signaling pathway
that involves ubiquitylation of ENaC does not seem to be absolutely required for the aldosterone-mediated
control of ENaC. These in vivo physiological studies presently constitute a major challenge for our
understanding of the regulation of ENaC to maintain the Na+ balance.+41 21 692 53 55.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
A major challenge for the kidney is to maintain the osmolality and
the composition of extracellular ﬂuid volume within a very narrow
margin; indeed to keep the extracellular volume constant, the kidney
has to balance precisely the urinary excretion of electrolytes and water
with the daily intake of salt and ﬂuid. To this end, the urinary electrolyte
and water excretion is under the tight control of aldosterone and
vasopressin. These hormones act on target cells in the distal part of the
nephron and on the collecting tubules of the kidney; these cells share
the expression of the epithelial sodium channel (ENaC), the mineral-
ocorticoid receptor (MR), the aquaporin-2 (AQP-2) and the vasopressin
receptor (V2R). These channels and receptors are central to sustain a
hormonally controlled Na+ and water reabsorption.The cellular expressionof ENaC isnot uniquely restricted to thedistal
nephron and the collecting tubules; ENaC is expressed in the colon
where, under the control of glucocorticoids, it mediates Na+ absorption
from the intestinal lumen [1]. The contribution of ENaC in the colon to
the maintenance of the whole body Na+ homeostasis still needs to be
carefully evaluated. In addition, ENaC is expressed in the lung to
maintain the composition of the air-surface liquid, aswell as in exocrine
glands where it sets the ionic composition of the exocrine secretions
(sweat); a major contribution of ENaC in those latter epithelia in the
control of the whole body Na+ balance is however unlikely.
The importance of the aldosterone-sensitive distal nephron in
maintaining extracellular electrolyte and water balance is nicely
demonstrated by the elucidation of the genetic basis of rare monogenic
forms of hypertension, due to mutations in the genes coding for ENaC,
the mineralocorticoid receptor, or enzymes crucial for the synthesis of
aldosterone [2].
The purpose of this review is to bridge our knowledge about the
structural and functional characteristics of ENaC observed in vitro, with
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evidenced in recently available animal models.2. Structural and functional aspects of ENaC
ENaC belongs to a family of ion channels that includes the neuronal
acid-sensing ion channels (ASIC1, ASIC2, and ASIC3) in mammals,
touch-activated ion channels called degenerins in C. elegans, and a
variety of homologs in Drosophila, mollusks; so far no homologous
proteins have been identiﬁed in prokaryotes [1].
ENaC is a highly Na+ selective channel made of three α, β, and γ
homologous subunits [3]. The α subunit is absolutely required for
channel activity,whereas theβ andγ arenecessary formaximal channel
expression and activity at the cell surface. Several biochemical and
functional evidence are consistent with a heterotetrameric structure of
the channel, likely comprising 2α, 1β and 1γ subunits [4–6]. However
this subunit architecture of ENaC needs to be revisited since the recently
reported crystal structure of an ASIC channel isoform (ASIC1A) shows a
trimeric oligomerization [7]. The tridimensional structure of the
individual ASIC1A subunit is consistent with early studies on the
membrane topology of ENaC α, β, and γ subunits, that proposed two
transmembrane segments, intracellular N- and C-termini, and a large
extracellular loop thatmakes ofmore thanhalf of the channel protein [8]
(Fig. 1). The large extracellular domain is essential for channel function,
but its role in supporting Na+ ion ﬂow through the channel, or in
channel gating remains unclear. Mutagenesis studies of ENaC predicted
that the second transmembrane (TM2) α helix of each subunit is
arranged pseudosymmetrically around a central axis forming an ion-
conducting channel [9]. The cytosolic N-terminus contains domains that
regulate channel gating and likely as well the pore opening on the
cytosolic side [10]. The C-terminus of each subunit contains a proline-
rich domain involved in speciﬁc interactions with regulatory proteins.
ENaC is a constitutivelyopenchannel localizedat theapicalmembrane
of principal cells and displaying a short half-life of residency (less than
1 h) [11,12]. ENaC activity can be inhibited by pharmacological blockersFig. 1. Homology models of ENaC subunits based on the crystal structure of ASIC channel:
predicted structures of the α (green), β (red) and γ (yellow) ENaC subunits based on the 3
extracellular domain that represents more than half of the mass of the protein. The two tra
lining the pore. The crystal obtained for ASIC1a did not allow the resolution of the structure
homology models of α, β and γ subunits.such as triamterene or amiloride that act from the extracellular side and
bind a common site on the TM2 segment lining the channel pore [13].
In the kidney, ENaC is expressed in the aldosterone-sensitive distal
nephron (ASDN), a region that includes successively, the late portion
of the distal convoluted tubule (DCT), the connecting tubule (CNT)
and the collecting duct (CD) [14]. In spite of their different embryonic
origin, all three nephron segments share in common the expression of
ENaC, the mineralocorticoid receptor (MR) and the 11-β hydroxys-
teroid dehydrogenase type-2, the enzyme that confers to the MR
receptor, a functional mineralocorticoid speciﬁcity [15,16]. The
subcellular location and the level of expression of ENaC subunits
change drastically upon the elevation of plasma aldosterone levels in
response to sodium diet [17,18]. In rodents under standard Na+ diet
(the “European diet”) associated with moderate plasma aldosterone
levels, ENaC subunits are detectable by immunohistochemistry in the
cytosol of principal cells, with a discrete labeling of the apical
membrane of the late DCT and the CNT. Under low Na+ diet leading to
high plasma levels of aldosterone in these animals, ENaC subunits
decorate the apical membrane of principal cells of the DCT, CNT and
CD, with a prominent expression in the early ASDN compared with
the late ASDN.
This axial distribution of ENaC along the ASDN, which has also been
observed by immunohistochemical experiments, was corroborated by
elegant patch-clamp experiments onmicrodissected ASDN segments of
rats kept under different Na+ diets: under normal Na+ diet there were
nomeasurable amiloride-sensitivewhole-cell currents in principal cells
of the CNT or CCD. In contrast, under low Na+ diet with high plasma
levels of aldosterone, a signiﬁcant amiloride-sensitive current could be
detected which was more prominent in the CNT, and decreased along
the CCD [19]. These results indicate that the adaptation of the renal
excretion of Na+ in response to Na+ diet occurs predominantly in the
early ASDN.
ENaC in the apical membrane of principal cells is the major entry
pathway for Na+ ions from the tubule lumen into the cell (Fig. 2): Na+
ions enter the cell across the apical membrane along a favorable
electrochemical gradient [20]. The vectorial transport of Na+ acrossα ENaC (green), β ENaC (red), and γ ENaC (yellow). This homology model shows the
D structure obtained for the ASIC1a channel. These homologous subunits show a large
nsmembrane domains (TM1 and TM2) consist of α helices, and the TM2 is involved in
of the amino and the carboxy termini, and therefore are absent as well in the present
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basolateral membrane that pumps the Na+ ions out of the cell into the
interstitium. Since ENaC is a constitutively open channel with an open
probability averaging 0.4, all the factors that control the number of
active channels at the cell surface will have a more profound effect on
Na+ absorption in the ASDN and in the amount of Na+ that is excreted
in the ﬁnal urine, than factors affecting essentially channel gating [21].3. Regulation of ENaC activity
From functional investigations in heterologous expression systems,
ENaC was found to be stimulated, by soluble proteases such as trypsin,
chymotrypsin, elastase, thrombin or kallikrein [22,23]. In addition,
membrane-bound proteases increase ENaC activity at the cell surface;
they were identiﬁed by functional cloning in Xenopus oocytes, and
subsequently by homology cloning. Among these proteases, the ﬁrst to
be identiﬁed was named CAP-1 (channel activating protease-1) and is
anortholog of thehumanprostasin [24,25]. Subsequently,mouseCAP-2,
anortholog of thehuman transmembraneprotease serine 4 (TRPMSS4),
and another mouse CAP-3 (ortholog of the matriptase or epithin) were
shown to stimulate ENaC to a similar extend [26]. Finally the
identiﬁcation of a cleavage sequence for the furin-like protein-
convertase in the extracellular domain of the α and γ ENaC subunits,
led to the demonstration of the role of furin in ENaC cleavage, ENaC
sorting and activity at the cell surface [27–29]. A number of cleavage
sites for thesemembrane-boundproteases in the extracellular loop ofα,
β, and γ subunits have been identiﬁed, indicating that ENaC is the likely
substrate of these proteases [30].Fig. 2. Model of ENaC regulation by aldosterone and vasopressin. Upon binding of aldoster
translocates into the nucleus where it binds to speciﬁc DNA responsive elements. This lead
transcripts) such as ENaC, the Na/K-ATPase, or SGK1 and, alternatively, to the repression of a
the G-protein coupled receptor V2R, which leads to activation of a downstream protein ki
retention of active ENaC at the cell surface. Ubiquitylated ENaC channels at the cell surface
vesicles back to the cell surface.The physiological relevance of the ENaC regulation mediated by
proteases is still not clearly understood, but indirect evidence suggests
thepresence of endogenously expressedmembrane-boundproteases in
epithelia and their possible role in ENaC activation. Indeed, soluble
proteases are inefﬁcient to further increase ENaC activity in kidney
epithelial cells, although serine protease inhibitors such as aprotinin
have been shown to reduce baseline ENaC activity [25]. Assessing the
abundance of ENaC channels at the cell surface by surface biotinylation
in intact kidneys of rats under different salt diet, Frindt and Palmer
found that the expression and the cleavage of γ ENaC increased under
low Na+ diet, and that γ ENaC cleavage represents the parameter that
best correlated with the increase in ENaC activity [31]. However, the
precise molecular and cellular mechanisms responsible for ENaC
activation remain largely unknown. Whether these proteases are able
to directly interact with ENaC, or whether they act sequentially on the
channel activity remains to be determined.
When active at the cell surface, ENaC gating (i.e. channel open
probability) is relatively poorly controlled under physiological condi-
tions: cellular stress linked to unphysiological conditions such as the
increase of extracellular or intracellularNa+ concentrations, or a drop in
intracellular pH, a rise in intracellular Ca2+, and intracellular oxidative
stress, are all factors that tend to decrease the channel open probability;
the closure of the channel is likely important to preserve the cell from a
massive entry ofNa+ ions thatwouldovercomethepumping capacity of
the Na+/K+-ATPase [32–35]. Luminal ATP and UTP nucleotides have
been shown to reduce the open probability of ENaC; this effect is likely
mediated by an apical G-protein coupled P2Y2 receptor. Indeed the
inhibitory effect of ATP of ENaC activity in the cortical collecting duct in
vivo could not be observed in mice lacking the P2Y2 receptor, with anone to its receptor (MR), the complex ligand receptor dimerizes, and subsequently it
s both to the induction of a speciﬁc set of AIT transcripts (AIT = aldosterone-induced
number of transcripts (ART= aldosterone-repressed transcripts). Vasopressin binds to
nase A (PKA). Both SGK1 and PKA inactivate Nedd4 upon phosphorylation, leading to
are internalized; deubiquitylation by USP2-45 allows ENaC to recycle from endocytic
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aldosteronemay contribute to a decreasedNa+ absorption under a high
sodium diet.
The regulation of Na+ absorption in the ASDN relies more on the
number of active ENaC channels at the apical membrane of principal
cells than on the modulation of channel gating itself. The number of
active ENaC channels at the cell surface is tightly controlled by
aldosterone and vasopressin. The main determinants of the stability of
ENaC at the cell surface are nowquitewell understood. Ubiquitylation is
a general process that regulates the stability of a variety of target
proteins; mono or multi-ubiquitylation can serve as signal for
endocytosis of transmembrane proteins, a process that usually results
in their degradation by the lysosome and/or the proteasome [37].
Nedd4 E3 protein–ubiquitin ligases that belong to the HECT family,
contain 3–4WWdomains responsible for binding to canonical PYmotifs
of the target substrates; such PYmotifs are found at the C-termini of the
β and the γ subunits of ENaC [38] and are essential for efﬁcient mono-
ubiquitylation of speciﬁc lysine residues in the N-termini of β or γ ENaC
by the HECT domain of Nedd4-2. In Xenopus oocytes, Nedd4-2 was
shown to efﬁciently suppress ENaC activity by ubiquitylation of the
functional channel complex at the cell surface, leading to clathrin-
mediated endocytosis and degradation [39]. Enzymes that are able to
deubiquitylate ENaC such as UCH-L3 or Usp2-45, have been shown to
increase ENaC-mediated Na+ current in vitro, further supporting the
role of ubiquitylation in regulating ENaC stability at the cell surface [40].
As mentioned before, aldosterone essentially increases the number
of active ENaC channels at the cell surface [18]. Different approaches
have been used to identify aldosterone-induced transcripts, in order to
decipher the aldosterone-signaling cascade. Aldosterone induces the
phosphatidylinositide 3′-kinase(PI3K)-dependent kinase SGK-1
(serum- and glucocorticoid-regulated kinase 1), a Ser/Thr kinase that
elevates ENaC level and activity at the cell surface in heterologous
expression systems [41]. Subsequently, SGK-1 was found to phosphor-
ylate Nedd4-2, leading to a decreased interaction and ubiquitylation of
ENaC subunits, ﬁnally resulting in an increased ENaC activity at the cell
surface (Fig. 2) [42]. Other aldosterone-induced transcripts have been
identiﬁed, in particular the deubiquitylating enzyme Usp2-45, which
also increases ENaC activity at the cell surface in vitro [43]. These
observations suggest that the regulation of ENaC activity by aldosterone
is mediated at least in part by inhibition of Nedd4-2-dependent
ubiquitylation of ENaC, that ultimately tends to increase the number
of active channel at the cell surface [44].
In addition to aldosterone, vasopressin also increases ENaC activity
in the ASDN [45]. Vasopressin binds the V2 receptors, stimulating the
release of cAMP, which in turn increases the density of ENaC channel
at the cell surface [46,47]. In vitro studies indicate that PKA, much like
SGK-1, also phosphorylates Nedd4-2, providing a cellular mechanism
for the positive regulation of ENaC by vasopressin [48]. PKA and SGK1
phosphorylate the same residues of Nedd4-2. However, the converg-
ing phosphorylation of Nedd4-2 by these two kinases does not explain
the additive effects of vasopressin and aldosterone on ENaC-mediated
Na+ absorption in the ASDN [45]; therefore, other mechanisms are
most likely involved in the regulation of ENaC by PKA.
Still, the regulation of Nedd4-2 remains poorly understood. The
phosphorylation of Nedd4-2 by SGK1 and PKA stabilizes the interaction
of Nedd4-2 with 14-3-3 scaffolding proteins, preventing the Nedd4-2
dependent ubiquitylation of ENaC [49]. Interestingly 2 isoforms of the
14-3-3 proteins are induced by aldosterone, as SGK1. Another 14-3-3
binding protein have recently been identiﬁed that controls the
trafﬁcking of ENaC from an intracellular compartment to the cell
surface: this binding partner, AS160, is a Rab GTPase-activating protein
(Rab-GAP) known to play a role in GLUT4 transporter to the plasma
membrane in response to insulin [50]. In CCD cells, AS160 phosphor-
ylation, possibly by SGK1, allows ENaC trafﬁcking to the cell surface,
providing a mechanism for endocytosed ENaC to recycle to the cell
surface.In parallel to the SGK1/Nedd4-2 pathway that stabilizes ENaC at the
cell surface, a signaling cascade involving the Raf-1-MAPK/ERK kinases
acts to inhibit the cell surface expression of ENaC by stimulating the
interaction between Nedd4-2 and ENaC [51,52]. Interestingly, the
activation of ERK could be inhibited by another aldosterone-induced
protein in a cortical collecting cell line, the glucocorticoid-induced
leucine zipper protein (GILZ).
These studies essentially performed in vitro on heterologous
expression systems or in cortical collecting duct cell lines, identify
Nedd4-2 as a critical convergence point for the regulation of ENaC at the
cell surface.
4. ENaC and human diseases
Liddle's syndrome is an autosomal dominant form of salt-sensitive
hypertension with early onset of elevated blood pressure during
adolescence; this hypertension is usually associated with hypokalemia,
metabolic alkalosis, low plasma aldosterone, and suppressed plasma
renin activity [53]. The elevated blood pressure in Liddle syndrome can
be normalized under salt restriction and amiloride treatment. Based on
these clinical evidences, G.W. Liddle postulated that the syndrome was
“a disorder in which the renal tubules transport ions with such
abnormal facility that the end result simulates that of a mineralocor-
ticoid excess” [54]. Notably, the antinatriuretic response to aldosterone
was maintained in those patients, despite the low plasma aldosterone
levels. The mutation identiﬁed in the index case, is a 45 amino acid
deletion in the cytosolic C-terminus of the β ENaC subunit. Despite the
fact that Liddle's syndrome is a very rare condition, subsequent genetic
analysis of other Liddle's syndrome families revealed corresponding
deletionmutations in the C-terminus of theγ ENaC subunit, but none in
the α subunit [55]. Furthermore, missense mutations causing Liddle's
syndrome identiﬁed the target amino acid sequence in the β and γ C-
termini that involves the conserved proline-richmotif (the canonical PY
motif) [56–59].
Important for our understanding of Liddle's syndrome, ENaC
channels expressed from synthetic RNA and carrying the mutations
associated with Liddle's syndrome exhibit an increased channel activity
in Xenopus oocytes and in a cortical collecting duct cell line [46,60]. This
gain of function of themutated channels results from both, an increased
numberof active channels at the cell surface, and ahigher probability for
the channel to remain open [61]. The gain of function of ENaC mutant
channels is consistent with Liddle's hypothesis; the understanding of
the cellular and molecular mechanisms underlying these gain of
functionmutations essentially came from further studies in theXenopus
oocyte expression system.
As already mentioned, the PY motifs of β and γ ENaC bind the
ubiquitin ligase Nedd4-2which is responsible for the ubiquitylation of
the active channel complex at the cell surface, and the subsequent
targeting of the channel for endocytosis and lysosomal degradation. In
Liddle's syndrome, deletion or missense mutations of PY motifs in the
β or γ impair the ability of Nedd4-2 to bind and thus ubiquitylate the
channel, leading to the accumulation of active ENaC channels at the
cell surface [62].
Pseudohypoaldosteronism type 1 (PHA-1) is characterized in the
ﬁrst week of life by severe dehydration, hyponatremia, and hyperka-
lemia [63]. There are two clinically distinct forms of (PHA-1), an
autosomal recessive form affecting multiple organs (systemic form),
including the kidneys, colon, salivary glands, and sweat ducts (but not
the skin, or inner ear, for instance) and an autosomal dominant form
restricted to the kidney. Patients with a systemic form of PHA-1 have
mutations in α, β and γ ENaC subunits [63]. Mutations in the α, β or γ
ENaC genes include nonsense, frameshift or missense mutations
leading to channel loss of function, and the clinical severity of the
syndrome correlates with the extent to which ENaC activity is
reduced. The autosomal dominant form of PHA-1 is caused by
mutations of the mineralocorticoid receptors [64]. Thus, both Liddle's
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the ASDN for themaintenance of thewhole body sodium homeostasis.
5. Mouse models
A variety of genetic mouse models have been generated to study in
vivo the physiological and pathophysiological roles of ENaC in the
maintenance of whole body salt balance, and in the control of blood
pressure. Constitutive inactivation of all three ENaC subunits in mice
clearly showed the importance of ENaC in Na+ and K+ handling by the
kidney: mice lacking the α subunit of ENaC died soon after birth from
hyperkalemia,metabolic and respiratory acidosis, andpulmonary edema
due to impaired lung ﬂuid clearance [65]. The constitutive β and γ ENaC
null-mice exhibit a milder pulmonary phenotype and essentially renal
features that involve increased Na+ excretion, K+ retention, and
elevated plasma aldosterone [66,67]. Using a gene targeting approach,
α ENaC expression was selectively abolished in the CCD segment of the
ASDN; interestingly these CCD-speciﬁc KO mice do not exhibit any
impairment in Na+ nor in K+ handling by the kidney to maintain
electrolyte balance, asmade evidentbyplasmaaldosterone levels similar
to those in wt mice, suggesting that the absence of ENaC-mediated Na+
absorption and K+ secretion in the CCD can be compensated in other
parts of the nephron [68]. These observations also suggest that the late
DCTandCNTare themain regulatory sites ofNa+andK+excretion in the
ASDN and conﬁrm the axial gradient of ENaC expression along the distal
nephron. Obviously, these experiments do not address the role of the
ENaC-mediated Na+ absorption in the colon in the maintenance of Na
balance; the answer to this question awaits the study of additional
tissue-speciﬁc ENaC KO mouse models to investigate the ability of the
colon to retain salt under salt deprivation.
To obtain new insights into the pathophysiology of salt-sensitive
hypertension, amousemodel of Liddle's syndrome has been developed,
with the deletion of the C-terminal end of the β ENaC subunit [69].
Under normal salt diet, these mice develop normally with a blood
pressure similar to their wild type counterparts of identical genetic
background. However, under high salt diet the Liddlemice develop high
blood pressure, hypokalemia, metabolic alkalosis, low plasma aldoste-
rone, a proﬁle that recapitulates Liddle's syndrome.
The mouse model of Liddle's syndrome with the mutation in the
PY motif of β ENaC, together with the Nedd4-2 KO and SGK1 KO
mouse models allow a genetic dissection of some of the important
converging points of the aldosterone-signaling pathway.
Measurements of ENaC-mediated currents by the whole-cell
patch-clamp technique on microdissected collecting tubules revealed
that, under normal salt diet, the currents measured in both wt and
Liddle principal cells were undetectable [70]; the interpretation of
these data is not clear. A possibility is that, although ENaC activity is
undetectable under these experimental conditions, it might be
however sufﬁcient to drive enough Na+ to generate hypervolemia
and hypertension. However under low salt diet with high plasma
aldosterone, Liddle mice had a much larger ENaC-mediated current
compared to wt. This demonstrates that ENaC lacking the PY motif in
the C-terminus of β ENaC and thus displaying defective interactions
with Nedd4-2, are still highly sensitive to stimulation by aldosterone.
These data obtained in vivo indicate that the Nedd4-2 signaling
cascade does not constitute the predominant pathway for aldoste-
rone-mediated upregulation of ENaC. Rather they suggest that Liddle's
syndrome constitute a state of hypersensitivity to aldosterone, with
an exacerbated response to physiological plasma levels of the
hormone. In the colon of Liddle mice, ENaC channels also retain
their sensitivity to aldosterone [71].
TheNedd4-2knockoutmice (Nedd4-2−/−) have a slight elevationof
BP under normal salt diet that was exacerbated under high Na+ diet
[72]. A tendency to lower plasmaaldosterone levelswasobservedunder
normal salt diet that became signiﬁcant under low salt diet. At the
protein level, the expression of all three ENaC subunits in the wholekidney was increased together with that of the NaCl cotransporter
(NCCT). ENaC activity directly measured in the colon by recordings of
the rectal transepithelial and amiloride-sensitive potential difference,
remains sensitive to stimulation by aldosterone. Interestingly, and by
contrast to ‘Liddle’ mice, no hypokalemia was detected, but rather a
signiﬁcant hyperkalemia under normal Na+ diet was observed in the
Nedd4-2−/−mice; this suggests an increased activity of both ENaC, and
likely the NCC cotransporter that might play a role in the hypervolemia
and hypertension in the Nedd4-2−/−mice.
Two independent SGK1 knockoutmice SGK−/−have been generated
[73,74]: both mice models are viable and do not exhibit any major
phenotype, andnoevidence for a salt loosingnephropathyunder normal
salt diet. This contrasts with the severity of the renal phenotype of both
the ENaC knockout and the mineralocorticoid receptor (MR) knockout
mice [65,75].Whenput on lowNa+diet, both SGK+/+ andSGK−/−mice
reduced their urinary Na+ excretion, but the SGK−/− showed a higher
natriuresis under this condition. In one SGK−/− model, the natriuresis
under chronic aldosterone treatment (1 wk) or low Na+ diet was
correlated with ENaC activity in the CCD recorded by whole-cell patch-
clamp technique [74]. As reported in othermousemodels, under normal
Na+ diet, no detectable amiloride-sensitive current could be measured
in either mice SGK+/+ or SGK−/−; however, under chronic aldosterone
treatment a robust amiloride-sensitive current was measured that was
undistinguishable between SGK−/− and SGK+/+ mice. Furthermore,
after 2–3 days of Na+ restriction, SGK−/− mice displaying a higher
natriuresis compared to wt, showed a higher ENaC activity as measured
by the amiloride-sensitive Na+ current, together with a higher plasma
aldosterone level [74]. This again suggests that Na+ transporters other
than ENaC in upstream tubular segments, are defective in the SGK−/−.
Thesemicemodels indicate that the signaling pathway that involves
SGK1 and Nedd4-2 is not absolutely required for aldosterone-mediated
control of ENaC, and if physiologically relevant, this pathway likely plays
only a minor role in ENaC-mediated regulation of Na+ balance. The
other signaling pathways responsible for the modulation of ENaC
activity remain to be identiﬁed. Interestingly, the SGK1–Nedd4-2
pathway might play an important role in controlling aldosterone-
sensitive NCC activity and Na+ absorption in the DCT.
6. Conclusions
From genetic studies and mouse models it is now recognized that
ENaC in the ASDN, under the control of aldosterone and vasopressin,
plays a key role in the ﬁne adaptation of urinary Na+ excretion in
order to precisely balance the daily intake of salt. The control of this
Na+ balance is essential for the maintenance of the extracellular ﬂuid
volume and blood pressure.
A number of uncertainties still persist in our understanding of
regulation of ENaC activity. Two signaling pathways have been
described in vitro and in cultured cell lines that regulate ENaC trafﬁcking
and activity; in addition, proteases are involved in the processing of
ENaC activation. Studies on animal models allowing the genetic
dissection of these ENaC regulatory pathways are now needed to
establish their physiological relevance in the maintenance of sodium
homeostasis, in the control of the extracellular ﬂuid volume and blood
pressure. The presently available models suggest the presence of
alternative pathways than those involving Nedd4-2 and SGK1, in the
hormonal regulation of ENaC, that need to be considered.
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